Brochure | April 17, 2019

Particle Control In Biopharmaceuticals

Source: Lonza Pharma & Biotech

Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose. Download the brochure to learn more about Lonza’s state-of-the-art analytical methods to quantify and characterize particles in biopharmaceuticals.